500,000 immigrants at risk for deportation after Supreme Court ruling
The Supreme Court on Friday allowed the Trump administration to revoke the temporary legal status of more than 500,000 immigrants that was granted by the Biden administration, making them subject to deportation. NBC News' Ryan Chandler has the details.May 31, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Leader Live
10 minutes ago
- Leader Live
Nigel Farage uses visit to Scotland to double down on attacks on Anas Sarwar
Mr Farage claimed the Scottish Labour leader has a 'record of obsession' – citing a speech he gave in Holyrood in 2020 as evidence of this. His comments came as he unveiled a new defection to his Reform UK party, with councillor Duncan Massey, who had been a Conservative representative on Aberdeen City Council, now a member. Mr Farage also promised another defection, this time from Labour, would come on Monday afternoon as he visits Hamilton, where a Holyrood by-election is taking place. That by-election has been dominated by a row over a Reform advert which has been branded 'racist' by Reform's opponents, and which claims that Mr Sarwar will 'prioritise' the Pakistani community in Scotland. Asked about this, Mr Farage insisted Reform UK 'don't talk about race at all'. He pointed out his party's chairman, Zia Yusuf, was someone who 'is Scottish born, but comes from parents who come from the Indian subcontinent'. Mr Farage continued: 'We think everybody should be treated equally. We object, very strongly, to the segmentation of people into different types.' Adding that the Scottish Labour leader has a 'record of obsession on this issue', he went on to reference a speech Mr Sarwar gave in 2020 where he noted that key figures across Scotland, from the judiciary, to council chief executives to head teachers, were all white. Mr Farage said: 'I think that speech he gave was sectarian in its very nature – we are the south Asian community, we are going to take over the country and take over the world. 'We believe what he said was a form of sectarian politics and we don't like it one little bit.' His comments came after First Minister John Swinney claimed the Reform UK leader 'doesn't care about Scotland'. Welcome to Lower Deeside Councillor Duncan Massey ✅ Scotland needs Reform. Be part of it ➡️ — Reform UK Scotland (@ReformUKScot) June 2, 2025 With an opinion poll having suggested Reform could be the second-largest party at Holyrood after next May's Scottish elections, the SNP leader spoke about the 'deeply concerning rise in support for Farage'. Mr Swinney added: 'Be in no doubt, Nigel Farage doesn't care about Scotland. He poses a threat to our values and must be stopped, and only the SNP can do that.' Mr Farage however declared that his party had 'made remarkable strides in Scotland over the past year'. Speaking as protesters gathered outside, the Reform UK leader said if the polls are to be believed 'we are beginning to eclipse Labour to be the second most popular party in Scottish politics'. Mr Farage again spoke out about the 'madness' of the net zero policies being pursued by the governments at Holyrood and Westminster. He told reporters these had left the oil and gas industry, which is centred in Aberdeen, 'in serious decline'. This 'to a large extent… is wholly unnecessary', the MP insisted, hitting out at the taxes imposed on the oil and gas sector, and also at the Labour Westminster Government's opposition to licensing new fields. Mr Farage continued: '2025 will be a year of record consumption of fossil fuels. 'We can con ourselves as much as we like, there will be more coal burnt this year than has ever been burnt in the history of mankind, and the same applies to gas and oil. 'Even the most ardent proponent of net zero has to accept the world will still be using oil and gas up until 2050 and beyond. 'And yet we have decided to sacrifice this industry as a consensus around net zero has emerged.' As a result of this he said parts of Scotland, England and Wales were 'literally deindustrialising before our very eyes'. Mr Farage said: 'The madness of this is almost completely and utterly beyond belief.' Asked about the upcoming Hamilton by-election, Mr Farage said he was confident his party would place at least third, but if Reform won it would be the 'biggest earthquake Scottish politics has ever seen'. Responding to the Reform UK leader's latest comments on Monday, Mr Sarwar said: 'Today the chief clown Nigel Farage finally found his way to Scotland and showed just how totally out of touch with our country he is. 'Nigel Farage turned up, admitted he can't win the Hamilton, Larkhall and Stonehouse by-election, and pledged to cut funding for Scotland's NHS and public services. 'Nigel Farage is a dangerous clown and the people of Scotland see right through him.' In an interview with the Scottish Sun on Monday, Mr Farage described Mr Swinney as 'anti-English' following his outspoken attacks on the Reform leader. 'Swinney's words are deeply provocative, which suggests the SNP leadership has learned nothing,' he told the newspaper. 'It suggests there is still that sort of quite unpleasant anti-Englishness. 'Why on earth would the top man in Scottish politics today come out with those sort of insults?' Speaking to the PA news agency on Monday, Mr Swinney rejected the claims. 'I've always taken forward my politics on the basis of inclusion, of welcoming people, of working with others – that's what I'm about,' he said. 'Nigel Farage is the opposite of that. 'Nigel Farage stokes division, he seeks to put people against each other and we're bringing people together in Scotland to create the best future for our country.'
Daily Mail
12 minutes ago
- Daily Mail
Stop denying thousands of women with incurable breast cancer wonder drug that could boost survival almost 50%, NHS urged
A lifeline drug currently denied to thousands of women with incurable breast cancer could boost survival by almost 50 per cent, pivotal new research has suggested. Medics hailed the drug Enhertu after the trial showed it could extend the lives of patients with one of the hardest to treat forms of the disease, buying them an extra year or more of life. Campaigners said the new findings add to the 'betrayal' that they cannot get the life-extending treatment on the NHS in England or Wales when it is already available in Scotland. It follows repeated decisions by NHS spending watchdog the National Institute for Health and Care Excellence (NICE) to deny the 'wonder drug' on cost grounds using new criteria which does not class all terminal cancers as 'severe'. Also known as trastuzumab deruxtecan, it is a targeted treatment for patients with a an aggressive and fast-growing type of cancer, known as HER2-positive—accounting for roughly one in five cases of the disease. Researchers presenting the findings at the American Society of Clinical Oncology conference in Chicago said it showed Enhertu was a 'highly effective' drug that should become the first port of call for patients with this form of breast cancer. In the trial, women taking the drug alongside another treatment called pertuzumab, lived without their cancer growing for 40.7 months on average, compared to just 26.9 among those who took standard treatment—the drug trastuzumab and pertuzumab. Enhertu slashed the risk of death or the disease progressing by 44 per cent, they added. After two years, around 70 per cent of patients on the new combination had not seen their cancer grow or spread, compared to around 52 per cent on standard treatment. For those who had received the combination, 85 per cent saw their cancer shrink or disappear compared to 78.6 per cent in the standard treatment group. Dr Sara Tolaney, head of breast oncology at the Dana-Farber Cancer Institute in Boston and study lead author, said: 'This trial has the potential to establish a new first line treatment for advanced HER2-positive breast cancer, a setting which hasn't seen significant innovation in more than a decade. Trastuzumab deruxtecan is a 'highly effective' and 'promising' therapy, she added. Around 1,000 women each year in England could benefit from the drug, which patients described as 'the last roll of the dice'. Last year, after NICE prevented the drug from receiving NHS funding—a decision the charity Breast Cancer Now called 'a dark day for women with incurable breast cancer'—one 46-year-old patient told how Enhertu would give her more time with her seven-year-old daughter Grace. Former marketing professional, Kathryn Hulland, who lives in Devon, was diagnosed with breast cancer in 2020 and underwent chemotherapy and surgery to remove the tumour. She responded well, but at Christmas 2022 she found a lump on her neck and was told her cancer had returned and spread. Checking your breasts should be part of your monthly routine so you notice any unusual changes. Simply rub and feel from top to bottom, in semi-circles and in a circular motion around your breast tissue to identify any abnormalities She said: 'If my chemo stops working, there won't be many treatments left.' She added: 'Six months more with her would mean the world. It's heartbreaking that patients in Scotland can get it, but I can't. It's a lifeline I can't reach.' Following NICE's decision, in an unusual move the watchdog hit out at AstraZeneca, the British firm who manufactures Enhertu, accusing it of being 'unwilling to offer a fair price'. But the pharmaceutical giant said the drug—believed to cost about £120,000 a year per patient—was available in 18 other European countries, including Scotland. Breast cancer specialist and author Dr Liz O'Riordan told MailOnline today: 'This trial yet again shows the huge benefits Enhertu can offer women, giving them vital extra months and years. 'This postcode lottery is so unfair. It's a betrayal to patients in England and Wales that they cannot access Enhertu, when it is already available in Scotland. 'What more will it take for it to be approved.' Dr Catherine Elliott, director of research at Cancer Research UK, meanwhile told MailOnline: 'Treatments that target HER2-positive metastatic breast cancers have transformed outcomes for many people but most still see their cancer progress within two years of starting treatment. 'These trial results suggest that adding Enhertu to the standard treatment could prevent or slow the growth of this type of breast cancer beyond three years. 'Importantly, people given this treatment were also more likely to see their tumour shrink or disappear.'
BBC News
12 minutes ago
- BBC News
Pressley named Dundee head coach after Brentford exit
Dundee have appointed Steven Pressley as the Scottish Premiership club's new head 51-year-old former Scotland centre-half last week left Brentford, where he had spent four years as the Premier League club's head of individual player development, saying it was time for a "new challenge".Dundee say Pressley "emerged as the standout candidate" after "a thorough and comprehensive search process" to find a successor to Tony Docherty, who was sacked despite leading his side to safety from relegation on the final day of the season. More to follow.
